114 related articles for article (PubMed ID: 31892468)
1. Pulmonary metastases in newly diagnosed hepatocellular carcinoma: a population-based retrospective study.
Feng J; He Y; Wan J; Chen Z
HPB (Oxford); 2020 Sep; 22(9):1295-1304. PubMed ID: 31892468
[TBL] [Abstract][Full Text] [Related]
2. Trends in Incidence and Prognostic Factors of Two Subtypes of Primary Liver Cancers: A Surveillance, Epidemiology, and End Results-Based Population Study.
Yao J; Liang X; Liu Y; Li S; Zheng M
Cancer Control; 2022; 29():10732748211051548. PubMed ID: 35147456
[TBL] [Abstract][Full Text] [Related]
3. Combined Hepatocellular Cholangiocarcinoma: A Population-Based Retrospective Study.
Ramai D; Ofosu A; Lai JK; Reddy M; Adler DG
Am J Gastroenterol; 2019 Sep; 114(9):1496-1501. PubMed ID: 31335362
[TBL] [Abstract][Full Text] [Related]
4. Hepatocellular carcinoma in a low-endemic area: rising incidence and improved survival.
Witjes CD; Karim-Kos HE; Visser O; van den Akker SA; de Vries E; Ijzermans JN; de Man RA; Coebergh JW; Verhoef C
Eur J Gastroenterol Hepatol; 2012 Apr; 24(4):450-7. PubMed ID: 22273986
[TBL] [Abstract][Full Text] [Related]
5. Race/ethnicity-specific disparities in cancer incidence, burden of disease, and overall survival among patients with hepatocellular carcinoma in the United States.
Ha J; Yan M; Aguilar M; Bhuket T; Tana MM; Liu B; Gish RG; Wong RJ
Cancer; 2016 Aug; 122(16):2512-23. PubMed ID: 27195481
[TBL] [Abstract][Full Text] [Related]
6. Epidemiological trends of hepatocellular carcinoma in Austria.
Pinter M; Hucke F; Zielonke N; Trauner M; Sieghart W; Peck-Radosavljevic M
Dig Dis; 2014; 32(6):664-9. PubMed ID: 25376282
[TBL] [Abstract][Full Text] [Related]
7. The impact of liver resection on survival outcomes of hepatocellular carcinoma patients with extrahepatic metastases: A propensity score matching study.
Mao K; Yan Y; Zhang J; Wang J; Wang R; Ling X; Liu Y; Lau WY; Jiang S; Liu J; Xiao Z
Cancer Med; 2018 Sep; 7(9):4475-4484. PubMed ID: 30117307
[TBL] [Abstract][Full Text] [Related]
8. Combined hepatocellular-cholangiocarcinoma: a population level analysis of incidence and mortality trends.
Wang J; Li E; Yang H; Wu J; Lu HC; Yi C; Lei J; Liao W; Wu L
World J Surg Oncol; 2019 Feb; 17(1):43. PubMed ID: 30813932
[TBL] [Abstract][Full Text] [Related]
9. Treatment and outcomes of treating of hepatocellular carcinoma among Medicare recipients in the United States: a population-based study.
El-Serag HB; Siegel AB; Davila JA; Shaib YH; Cayton-Woody M; McBride R; McGlynn KA
J Hepatol; 2006 Jan; 44(1):158-66. PubMed ID: 16290309
[TBL] [Abstract][Full Text] [Related]
10. Utilization and outcomes of palliative therapy for hepatocellular carcinoma: a population-based study in the United States.
Davila JA; Duan Z; McGlynn KA; El-Serag HB
J Clin Gastroenterol; 2012 Jan; 46(1):71-7. PubMed ID: 22157221
[TBL] [Abstract][Full Text] [Related]
11. Impact of homogeneous and heterogeneous risk factors on the incidence and prognosis of brain metastases in patients with hepatocellular carcinoma.
Lin X; Zhang P; Huang R; Huang Y; Sun J; Zheng H; Tian X; Wang X
Ann Palliat Med; 2020 Sep; 9(5):2654-2667. PubMed ID: 32921091
[TBL] [Abstract][Full Text] [Related]
12. Hepatocellular Carcinoma Incidence Is Decreasing Among Younger Adults in the United States.
Rich NE; Yopp AC; Singal AG; Murphy CC
Clin Gastroenterol Hepatol; 2020 Jan; 18(1):242-248.e5. PubMed ID: 31042582
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of a nomogram to predict survival outcome among epithelial ovarian cancer patients with site-distant metastases: a population-based study.
Wang B; Wang S; Ren W
BMC Cancer; 2021 May; 21(1):609. PubMed ID: 34034697
[TBL] [Abstract][Full Text] [Related]
14. Is fibrolamellar carcinoma different from hepatocellular carcinoma? A US population-based study.
El-Serag HB; Davila JA
Hepatology; 2004 Mar; 39(3):798-803. PubMed ID: 14999699
[TBL] [Abstract][Full Text] [Related]
15. Insights into synchronous peritoneal metastases from hepatobiliary origin: Incidence, risk factors, treatment, and survival from a nationwide database.
Rijken A; Bakkers C; Klümpen HJ; van der Geest LG; de Vos-Geelen J; van Erning FN; de Hingh IHJT
Eur J Surg Oncol; 2023 Aug; 49(8):1436-1443. PubMed ID: 36898900
[TBL] [Abstract][Full Text] [Related]
16. Improving prognosis for patients with hepatocellular carcinoma in Ireland 1994-2008.
Gaynor C; Iqbal M; Comber H; Deady S; McCormick PA
Eur J Gastroenterol Hepatol; 2017 Feb; 29(2):221-224. PubMed ID: 27832038
[TBL] [Abstract][Full Text] [Related]
17. Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005.
Altekruse SF; McGlynn KA; Reichman ME
J Clin Oncol; 2009 Mar; 27(9):1485-91. PubMed ID: 19224838
[TBL] [Abstract][Full Text] [Related]
18. Sex and Race Disparities in the Incidence of Hepatocellular Carcinoma in the United States Examined through Age-Period-Cohort Analysis.
Zhang X; El-Serag HB; Thrift AP
Cancer Epidemiol Biomarkers Prev; 2020 Jan; 29(1):88-94. PubMed ID: 31712271
[TBL] [Abstract][Full Text] [Related]
19. Childhood liver tumors in Argentina: Incidence trend and survival by treatment center. A report from the national pediatric cancer registry, ROHA network 2000-2015.
Moreno F; Rose A; Chaplin MA; Cipolla MC; García Lombardi M; Nana M; Cervio G; Halac E; Viso M; Ayarzabal V; Bosaleh A; Liberto D; Sarabia E; Rizzi A; Morici M; Streitenberger P; de Dávila MTG
Pediatr Blood Cancer; 2020 Nov; 67(11):e28583. PubMed ID: 32737960
[TBL] [Abstract][Full Text] [Related]
20. Percutaneous CT-guided radiofrequency ablation for unresectable hepatocellular carcinoma pulmonary metastases.
Li X; Wang J; Li W; Huang Z; Fan W; Chen Y; Shen L; Pan T; Wu P; Zhao M
Int J Hyperthermia; 2012; 28(8):721-8. PubMed ID: 23153217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]